GOAL 3, Den Bosch (2026)

21/05/2026

𝐎𝐧𝐞 𝐰𝐞𝐞𝐤 𝐭𝐨 𝐠𝐨 𝐮𝐧𝐭𝐢𝐥 𝐨𝐮𝐫 𝐟𝐢𝐫𝐬𝐭-𝐞𝐯𝐞𝐫 𝐆𝐎𝐀𝐋 𝟑 𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧 𝐰𝐞𝐛𝐢𝐧𝐚𝐫, Exploring the Path to 100x Impact. Read more ⬇️

💯 Not all impact is equal. Some healthcare interventions achieve more than 100x the impact of others, saving significantly more lives at a fraction of the cost.

🏥 At GOAL 3, we work in severely under-resourced hospitals, where improving care is not about adding more resources, but about using existing resources far more effectively.
👉 How do you actually achieve that?
👉 How do you measure real impact?
👉 And if sustainable business models matter, what role does philanthropy still play?

📈 During our upcoming webinar, we will unpack the evidence behind our work, including how patient monitoring and clinical support through IMPALA have the potential to push impact beyond the 100x mark by reducing child mortality in hospitals.

💡 We will share what we know, what we are still learning, and how technology, innovative business models, and philanthropy can work together to drive lasting system change.

What to expect:
✅ Real-world insights from clinicians
✅ The evidence behind IMPALA
✅ Lessons from implementation in low-resource settings
✅ Live Q&A

This is a knowledge session, not a fundraising pitch.

If you are interested in achieving maximum impact where it needed the most, we would love for you to join us.

👉 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰 𝐯𝐢𝐚 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐛𝐞𝐥𝐨𝐰.

https://goal3.org/goal-3-foundation-webinar

📺 May 27 | 16:00–17:00 CET | Dutch
📺 June 3 | 16:00–17:00 CET | English

24/04/2026

𝐈𝐌𝐏𝐀𝐋𝐀 𝐢𝐬 𝐧𝐨𝐰 𝐥𝐢𝐯𝐞 𝐢𝐧 𝐊𝐞𝐧𝐲𝐚! 🇰🇪🎉

🏥 Last month we launched IMPALA in our first hospital in Kenya – Kenyatta National Hospital. (KNH)! Thanks to the vision of the KNH CEO, leadership, and clinical teams, 10 monitors were installed in the newborn unit alongside a big screen and tablets for the central patient overview. Our service coordinator from Malawi, Alice Likumbo, flew over to coordinate the installation as well as lead the training with clinicians, champions, and local biomedical engineers.

🧑🏽‍⚕️Soon after the installation, KNH and GOAL 3 co-organized a site visit for interested parties during the IMNHC Conference (AlignMNH), including participants from Gates Foundation, Beginnings Fund / ELMA Philanthropies, AFRICAN NEONATAL ASSOCIATION (ANA) and ArcHealth Foundation The staff had clear enthusiasm for IMPALA, and were quickly embracing its capabilities to improve the care in their hospital.

📈 Kenyatta is the second largest hospital in Africa, and is widely regarded by other health facilities as the benchmark for standard of care. This positions it as the ideal launchpad for GOAL 3 to enter the Kenyan market and expand across the country.

👏 We are grateful to the staff and management of Kenyatta who were enthusiastic about IMPALA from the moment they learned of it and have become real champions of IMPALA in Kenya.

23/04/2026

𝐖𝐞 𝐚𝐫𝐞 𝐩𝐫𝐨𝐮𝐝 𝐭𝐨 𝐬𝐡𝐚𝐫𝐞 𝐭𝐡𝐚𝐭 𝐰𝐞 𝐡𝐚𝐯𝐞 𝐬𝐢𝐠𝐧𝐞𝐝 𝐚𝐧 𝐌𝐨𝐔 (𝐌𝐞𝐦𝐨𝐫𝐚𝐧𝐝𝐮𝐦 𝐨𝐟 𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠) 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 𝐄𝐚𝐬𝐭 𝐂𝐞𝐧𝐭𝐫𝐚𝐥 𝐚𝐧𝐝 𝐒𝐨𝐮𝐭𝐡𝐞𝐫𝐧 𝐀𝐟𝐫𝐢𝐜𝐚 𝐇𝐞𝐚𝐥𝐭𝐡 𝐂𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲 (𝐄𝐂𝐒𝐀-𝐇𝐂). 🎉

🌍 This is an important milestone, not only for our collaboration, but for how proven health innovations can move faster from modest-scale success to wider public-sector adoption across the region.

🤝 ECSA-HC plays a unique regional role in strengthening health systems through coordination, technical assistance, knowledge sharing, training, and digitalization. That makes this partnership highly relevant for accelerating the scale-up of innovations in the public health sector, where the real challenge is often not proving that something works, but creating a credible pathway for adaptation, adoption, financing, and sustained implementation.

That is exactly why this matters for IMPALA.

🏥 IMPALA was built to help health workers in under-resourced settings detect deterioration earlier, prioritize care better, and use data more effectively. Our evidence to date shows that IMPALA can reduce the time spent on monitoring, ease pressure on overstretched teams, and contribute to better outcomes for children and newborns.

📈 But achieving SDG 3 will depend on more than strong innovations alone. It will depend on whether effective solutions can be scaled through real public systems in ways that are practical, sustainable, and country-led.

We believe this collaboration with ECSA-HC can help do exactly that.

👏 A special thank you to Dr Ntuli Kapologwe for the partnership, the trust, and the shared ambition to strengthen pathways for scaling innovations that can save lives and support frontline health workers.

🙌 We look forward to what comes next.

22/04/2026

𝐎𝐮𝐫 𝐈𝐌𝐏𝐀𝐋𝐀 𝐌𝐨𝐧𝐢𝐭𝐨𝐫 𝐡𝐚𝐬 𝐨𝐛𝐭𝐚𝐢𝐧𝐞𝐝 𝐂𝐄 𝐦𝐚𝐫𝐤𝐢𝐧𝐠! This is a big step forward in unlocking new opportunities to scale globally! 🎉📈

🌍 The CE mark is the European Union’s certification, under the new MDR: Regulation (EU) 2017/745 (MDR), that confirms a product meets strict standards for safety, health, and performance. For medical equipment designed for intensive-care settings, like IMPALA, achieving a Class IIb CE involves a long and rigorous assessment to ensure reliability in real-world use.

📁Securing CE marking requires tens of quality tests, hundreds of pages of technical files, and thousands of hours of work - this is why we are beyond excited on this major milestone!

𝐓𝐡𝐢𝐬 𝐢𝐬 𝐰𝐡𝐚𝐭 𝐨𝐛𝐭𝐚𝐢𝐧𝐢𝐧𝐠 𝐂𝐥𝐚𝐬𝐬 𝐈𝐈𝐛 𝐂𝐄 𝐦𝐚𝐫𝐤𝐢𝐧𝐠 𝐨𝐧 𝐈𝐌𝐏𝐀𝐋𝐀 𝐦𝐞𝐚𝐧𝐬 𝐩𝐫𝐚𝐜𝐭𝐢𝐜𝐚𝐥𝐥𝐲 𝐟𝐨𝐫 𝐆𝐎𝐀𝐋 𝟑:

➡️ CE is widely recognized globally as a trusted quality standard. Being CE marked makes it easier to obtain local regulatory approvals in new markets, allowing faster scaling of our system globally.

➡️CE marking enables international partners to work with us more easily. Large institutional stakeholders often have policies on only procuring CE marked products. With IMPALA now CE marked, it can now be bought by these institutions/partners, helping us grow and scale.

➡️ While IMPALA was designed for non-European settings, we have always aimed to meet the highest standards. Obtaining CE marking is a strong validation of the quality and safety of our system.

👏 We are immensely proud that IMPALA is now CE marked, and we are looking forward to seeing the literal CE stamp of approval on IMPALA soon.

Adres

Den Bosch

Website

https://goal3.org/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer GOAL 3 nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact

Stuur een bericht naar GOAL 3:

GOAL 3